A Novel Platform
to Improve
Cancer-Related
Health Outcomes*
A Novel Platform to ImproveCancer-Related Health Outcomes*
For Cancer Patients, Survivors & High Risk Individuals
* Interim analyses on Quality of Life Scores (QoLS) for cancer survivors from IRB Study NCT06397651.

Outcomes
Significant Interim Results in Lifestyle Modification Clinical Trial For Cancer Patients4
QoLs
Improvements in Sleep, Pain & Side-Effects ⁴
37%Side Effects27%Sleep Quality18%Pain Level
Quality of Life Score
+16-point Quality-of-Life Score Improvement ⁴

Projected 30% Reduction in Employer Costs for Cancer Patients ⁵
5: Interim Analysis from IRB Study NCT06397651
6: Cost Savings Projections based on Health Savings Model Validated by ADVI Health (USA).
Disclaimer: Complement1 should not be used in place of treatments recommended by users’ medical team.